We are live on ! Find out more
ACB

Aristotle Capital Boston Portfolio holdings

AUM $1.61B
1-Year Est. Return 19.82%
This Fund
S&P 500
This Quarter Est. Return
+8.48%
1 Year Est. Return
+19.82%
3 Year Est. Return
+51.6%
5 Year Est. Return
+74.11%
10 Year Est. Return
+400.29%
AUM
$1.12B
AUM Growth
+$220M
Cap. Flow
+$151M
Cap. Flow %
13.52%
Top 10 Hldgs %
17.31%
Holding
125
New
2
Increased
90
Reduced
32
Closed
1

Sector Composition

Rank Sector Weight
1 Industrials 21.69%
2 Technology 16.96%
3 Financials 14.78%
4 Healthcare 12.79%
5 Consumer Discretionary 7.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NBHC icon
1
National Bank Holdings
NBHC
$1.9B
$21.6M 1.94%
606,581
+91,373
+18% +$3.03M
EFOR
2
Everforth Inc
EFOR
$960M
$20.5M 1.84%
382,624
-28,651
-7% -$1.43M
EEFT icon
3
Euronet Worldwide
EEFT
$3.19B
$20.4M 1.83%
214,958
+1,741
+0.8% +$165K
MMSI icon
4
Merit Medical Systems
MMSI
$4.82B
$19.7M 1.77%
465,682
-93,718
-17% -$3.78M
QTS
5
DELISTED
QTS REALTY TRUST, INC.
QTS
$19.3M 1.73%
368,077
+60,186
+20% +$3.21M
ALE
6
DELISTED
Allete
ALE
$19M 1.7%
245,336
+32,213
+15% +$2.41M
MSCC
7
DELISTED
Microsemi Corp
MSCC
$18.6M 1.67%
361,242
+43,930
+14% +$2.21M
CRI icon
8
Carter's
CRI
$1.43B
$18.2M 1.63%
184,239
+30,195
+20% +$2.69M
ITRI icon
9
Itron
ITRI
$4.48B
$18.1M 1.62%
233,535
+32,160
+16% +$2.33M
AEIS icon
10
Advanced Energy
AEIS
$10.1B
$17.9M 1.6%
221,197
+33,426
+18% +$2.42M
ROG icon
11
Rogers Corp
ROG
$2.09B
$17.4M 1.56%
130,645
-20,389
-13% -$2.42M
AER icon
12
AerCap
AER
$23.4B
$17.2M 1.54%
336,023
+48,827
+17% +$2.39M
PRXL
13
DELISTED
Parexel International Corp
PRXL
$17M 1.52%
193,064
+18,000
+10% +$1.58M
B
14
DELISTED
Barnes Group Inc.
B
$16.4M 1.47%
232,548
+36,733
+19% +$2.28M
BDC icon
15
Belden
BDC
$3.97B
$16.4M 1.47%
203,219
+30,227
+17% +$2.28M
EFII
16
DELISTED
Electronics for Imaging
EFII
$16.3M 1.46%
382,197
+58,225
+18% +$2.38M
FLWS icon
17
1-800-Flowers.com
FLWS
$252M
$15M 1.35%
1,527,698
+234,202
+18% +$2.2M
DY icon
18
Dycom Industries
DY
$11.2B
$15M 1.34%
174,833
+31,535
+22% +$2.66M
CHE icon
19
Chemed
CHE
$7.16B
$14.7M 1.31%
72,661
+5,250
+8% +$1.03M
QDEL icon
20
QuidelOrtho
QDEL
$1.13B
$14.1M 1.26%
320,360
-1,511
-0.5% -$52.6K
EVHC
21
DELISTED
Envision Healthcare Holdings Inc
EVHC
$13.4M 1.2%
298,891
+59,962
+25% +$3.2M
EPAY
22
DELISTED
Bottomline Technologies Inc
EPAY
$13.4M 1.2%
421,351
+65,715
+18% +$1.92M
CAMP
23
DELISTED
CalAmp Corp.
CAMP
$13.4M 1.2%
25,077
+3,752
+18% +$1.66M
WWE
24
DELISTED
World Wrestling Entertainment
WWE
$12.9M 1.16%
548,161
+104,037
+23% +$2.24M
MATW icon
25
Matthews International
MATW
$887M
$12.8M 1.15%
206,176
+31,826
+18% +$1.99M

Similar funds

Aristotle Capital Boston's Q3 2017 Portfolio in Review

As of Q3 2017, Aristotle Capital Boston held 125 positions worth $1.12B, up 25% from $896M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Aristotle Capital Boston deployed $151M of net new capital in Q3 2017, opening 2 new positions and adding to 90 existing holdings. Its largest new stake was Community Healthcare Trust: 271,951 shares worth $7.33M.

By sector, the portfolio is most concentrated in Industrials at 22% of assets, down from 22% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Merit Medical Systems, an estimated $3.78M trimmed.

  • Aristotle Capital Boston's largest Q3 2017 buy was Community Healthcare Trust: 271,951 shares worth $7.33M.
  • Aristotle Capital Boston added most to Nasdaq in Q3 2017, an estimated $3.81M increase.
  • Aristotle Capital Boston's biggest Q3 2017 reduction was Merit Medical Systems, cutting an estimated $3.78M.
  • Aristotle Capital Boston fully exited Neustar Inc in Q3 2017, selling an estimated $956K.
  • Aristotle Capital Boston's ten largest holdings make up 17% of its $1.12B portfolio in Q3 2017.
  • Aristotle Capital Boston opened 2 new positions and closed 1 in Q3 2017.
  • Aristotle Capital Boston's portfolio value rose 25% quarter-over-quarter to $1.12B.

Based on Aristotle Capital Boston's 13F filing for Q3 2017, filed 14 Nov 2017.